Thursday, 24 April 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 24 April 2025
News

Top earning CEO crown goes to...

Posted 22 April 2025 PM

Eli Lilly's David Ricks is now the highest paid CEO of a big pharma, joining his company at the top of the table.

Lilly has been on a tear in recent years, becoming the largest pharma by market cap in 2023 and improving its supply chain issues enough that obesity drug Zepbound made it to blockbuster status in 2024.

To see the whole article, please login

Popular

Biologics to double COPD market
Who's spending the most on HCPs?
Top earning CEO crown goes to...
PBS could become a 'brutal jungle'
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home